Clinical Trials Browser

INDUSTRY × volociximab × Genitourinary × Clear all

NCT00100685 2012-04-27

Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)

Phase 2 Terminated

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms